- Report
- October 2022
- 286 Pages
Global
From €2262EUR$2,500USD£1,932GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- June 2025
- 81 Pages
From €3122EUR$3,450USD£2,667GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3574EUR$3,950USD£3,053GBP
- Report
- June 2025
- 100 Pages
Europe
From €3574EUR$3,950USD£3,053GBP
- Report
- June 2025
- 89 Pages
North America
From €3122EUR$3,450USD£2,667GBP
- Report
- June 2025
- 109 Pages
Global
From €3122EUR$3,450USD£2,667GBP
- Report
- June 2025
- 81 Pages
Africa, Middle East
From €3122EUR$3,450USD£2,667GBP
- Report
- June 2025
- 198 Pages
Global
From €4479EUR$4,950USD£3,826GBP
- Report
- March 2025
- 145 Pages
Global
From €4389EUR$4,850USD£3,749GBP
- Report
- March 2023
- 26 Pages
Global
€11085EUR$12,250USD£9,469GBP
- Report
- July 2021
- 50 Pages
China
From €2353EUR$2,600USD£2,010GBP
- Report
- June 2021
- 50 Pages
China
From €2353EUR$2,600USD£2,010GBP
- Report
- May 2021
- 50 Pages
China
From €2353EUR$2,600USD£2,010GBP
- Report
- February 2024
- 108 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- October 2024
- 86 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- September 2024
- 98 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$4,143USD£3,094GBP
- Report
- September 2023
- 94 Pages
Global
From €3500EUR$4,143USD£3,094GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more